Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 4, 2004, Pages 735-743

  Woodford, Neil ^a   Ward, M E ^a   Kaufmann, M E ^a   Turton, J ^a   Fagan, E J ^a   James, D ^a   Johnson, A P ^a   Pike, R ^a   Warner, M ^a   Cheasty, T ^a   Pearson, A ^a   Harry, S ^a   Leach, J B ^b   Loughrey, A ^c   Lowes, J A ^d   Warren, R E ^e   Livemore, D M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b KINGSTON HOSPITAL   (United Kingdom)

^c BELFAST CITY HOSPITAL   (United Kingdom)

^d Southampton Laboratory   (United Kingdom)

^e PRINCESS ROYAL HOSPITAL   (United Kingdom)

Author keywords

Community infections; CTM M lactamases; ESBLs; Molecular epidemiology

Indexed keywords

AGAR; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEFALEXIN; CEFOTAXIME; CEFPODOXIME; CEFRADINE; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; FOSFOMYCIN; GENOMIC DNA; GENTAMICIN; IMIPENEM; MECILLINAM; MEROPENEM; NITROFURANTOIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TRIMETHOPRIM; UNINDEXED DRUG;

ALLELE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CHROMOSOME BANDING PATTERN; COMMUNICABLE DISEASE; CONTROLLED STUDY; DILUTION; DNA DEGRADATION; ENZYME SYNTHESIS; EPIDEMIC; ESCHERICHIA COLI; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HOSPITAL INFECTION; HOSPITAL PATIENT; MINIMUM INHIBITORY CONCENTRATION; MONITORING; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATIENT REFERRAL; PHENOTYPE; PHYLOGENY; POLYMERASE CHAIN REACTION; PUBLIC HEALTH; PULSED FIELD GEL ELECTROPHORESIS; STRAIN DIFFERENCE; STRAIN IDENTIFICATION; UNITED KINGDOM; URINARY TRACT INFECTION;

ALLELES; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; COMMUNITY-ACQUIRED INFECTIONS; CONJUGATION, GENETIC; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENES, BACTERIAL; GREAT BRITAIN; HUMANS; MICROBIAL SENSITIVITY TESTS; PHENOTYPE;

EID: 6344235543     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh424     Document Type: Article

References (27)

1. Bradford, P. A. (2001). Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clinical Microbiology Reviews 14 933-51.
2. Bonnet, R. (2004). Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrobial Agents and Chemotherapy 48, 1-14.
3. Poirel, L., Kampfer, P. & Nordmann, P. (2002). Chromosome-encoded Ambler class A β-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 46, 4038-40.
4. Poirel, L., Gniadkowski, M. & Nordmann, P. (2002). Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum β-lactamase CTX-M-15 and of its structurally related β -lactamase CTX-M-3. Journal of Antimicrobial Chemotherapy 50, 1031-4.
5. Radice, M., Power, P., Di Conza, J. et al. (2002). Early dissemination of CTX-M-derived enzymes in South America. Antimicrobial Agents and Chemotherapy 46, 602-4.
6. Walther-Rasmussen, J. & Hoiby, N. (2004). Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum β-lactamases. Canadian Journal of Microbiology 50, 137-65.
7. Baraniak, A., Fiett, J., Sulikowska, A. et al. (2002). Countrywide spread of CTX-M-3 extended-spectrum β -lactamase-producing microorganisms of the family Enterobacteriaceae in Poland. Antimicrobial Agents and Chemotherapy 46, 151-9.
8. Bou, G., Cartelle, M., Tomas, M. et al. (2002). Identification and broad dissemination of the CTX-M-14 β-lactamase in different Escherichia coli strains in the northwest area of Spain. Journal of Clinical Microbiology 40, 4030-6.
9. Alobwede, I., M'Zali, F. H., Livermore, D. M. et al. (2003). CTX-M extended-spectrum β-lactamase arrives in the UK. Journal of Antimicrobial Chemotherapy 51, 470-1.
10. Brenwald, N. P., Jevons, G., Andrews, J. M. et al. (2003). An outbreak of a CTX-M-type β-lactamase-producing Klebsiella pneumoniae: the importance of using cefpodoxime to detect extended-spectrum β-lactamases. Journal of Antimicrobial Chemotherapy 51, 195-6.
11. Mushtaq, S., Woodford, N., Potz, N. et al. (2003). Detection of CTX-M-15 extended-spectrum β-lactamase in the United Kingdom. Journal of Antimicrobial Chemotherapy 52, 528-9.
12. Reynolds, R., Potz, N., Colman, M. et al. (2004). Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme. Journal of Antimicrobial Chemotherapy 53, 1018-32.
13. CTX-M genes. Clinical Infectious Diseases 38, 1736-41.
14. Warren, R., Doroshenko, A., Carr, A. et al. (2004). Simultaneous bi-clonal outbreak of urinary tract infection by E. coli O25 strains with CTX-M-15:community and hospital effects in two English Health districts. Clinical Microbiology and Infection 10 Suppl. 3, 188 (abstract P756).
15. Andrews, J. M. (2004). BSAC standardized disc susceptibility testing method (version 3). Journal of Antimicrobial Chemotherapy 53, 713-28.
16. Saladin, M., Cao, V. T., Lambert, T. et al. (2002). Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiology Letters 209, 161-8.
17. Karim, A., Poirel, L., Nagarajan, S. et al. (2001). Plasmid-mediated extended-spectrum β-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiology Letters 201, 237-41.
18. CTX-M β-lactamase gene. Antimicrobial Agents and Chemotherapy 47, 2938-45.
19. CTX-M genes. FEMS Microbiology Letters 234, 201-7.
20. Kaufmann, M. E. (1998). Pulsed-field gel electrophoresis. In Molecular Bacteriology: Protocols and Clinical Applications (Woodford, N. & Johnson, A. P., Eds), pp. 33-50. Humana Press, Totowa, NJ, USA.
21. Eckert, C., Gautier, V., Saladin-Allard, M. et al. (2004). Dissemination of CTX-M-type β-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrobial Agents and Chemotherapy 48, 1249-55.
22. Gross, R. J. & Rowe, B. (1985). Serotyping of Escherichia coli. In The Virulence of Escherichia coli: Reviews and Methods (Special publication of the Society for General Microbiology no 13) (Sussman, M., Ed.), pp. 345-60. Academic Press, London, UK.
23. Bonnet, R., Recule, C., Baraduc, R. et al. (2003). Effect of D240G substitution in a novel ESBL CTX-M-27. Journal of Antimicrobial Chemotherapy 52, 29-35.
24. Cartelle, M., Del Mar, T. M., Molina, F. et al. (2004). High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution. Antimicrobial Agents and Chemotherapy 48, 2308-13.
25. Livermore, D. M. & Brown, D. F. (2001). Detection of β-lactamase-mediated resistance. Journal of Antimicrobial Chemotherapy 48, Suppl. S1, 59-64. Updated version available at http://www.bsac.org.uk/uploads/06.%20Detection%20of%20b- lactamase%20mediated%20resistance.pdf
26. Adedeji, A. (2004). Whom did you meet on your travels? Journal of Hospital Infection 57, 94-5.
27. Rodriguez-Bano, J., Navarro, M. D., Romero, L. et al. (2004). Epidemiology and clinical features of infections caused by extended-spectrum β-lactamase-producing Escherichia coli in nonhospitalized patients. Journal of Clinical Microbiology 42 1089-94.